Stocks
Avanos Medical (AVNS) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 172.8% | 153.8% | 158.5% | 158.5% | 152.8% | 144.4% | |||
| Changes by years, y/y, % | +98pp | -19pp | +5pp | 0pp | -6pp | +12.4% | |||
Avanos Medical. R&D/CAPEX, %
Avanos Medical. R&D/CAPEX, changes, pp
Avanos Medical (AVNS) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| R&D/CAPEX, % | 156.4% | 115.3% | 170.7% | 106.8% | 240.0% | 144.4% | ||
| Changes by years, y/y, % | +19pp | -38pp | -27pp | -63pp | +84pp | |||
| Changes by quarters, q/q, % | -14pp | -41pp | +55pp | -64pp | +133pp | |||
